Moreover, GSK3 inhibitors improve insulin sensitivity in rodent models of diabetes, alleviating hyperglycemia by decreasing hepatic gluconeogenesis and stimulating glycogen synthesis [24, 25]. The gene discussed is INS; the disease is diabetes mellitus.